The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Diabetic Angiopathies

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Diabetic Angiopathies


High impact information on Diabetic Angiopathies


Chemical compound and disease context of Diabetic Angiopathies


Biological context of Diabetic Angiopathies


Anatomical context of Diabetic Angiopathies


Gene context of Diabetic Angiopathies


Analytical, diagnostic and therapeutic context of Diabetic Angiopathies


  1. Modification of tissue-factor mRNA and protein response to thrombin and interleukin 1 by high glucose in cultured human endothelial cells. Boeri, D., Almus, F.E., Maiello, M., Cagliero, E., Rao, L.V., Lorenzi, M. Diabetes (1989) [Pubmed]
  2. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Crook, M.A., Pickup, J.C., Lumb, P.J., Giorgino, F., Webb, D.J., Fuller, J.H., Georgino, F. Diabetes Care (2001) [Pubmed]
  3. Sodium, blood pressure, and arterial distensibility in insulin-dependent diabetes mellitus. Lambert, J., Pijpers, R., van Ittersum, F.J., Comans, E.F., Aarsen, M., Pieper, E.J., Donker, A.J., Stehouwer, C.D. Hypertension (1997) [Pubmed]
  4. An unexpected cause of muscle pain in diabetes. Silberstein, L., Britton, K.E., Marsh, F.P., Raftery, M.J., D'Cruz, D. Ann. Rheum. Dis. (2001) [Pubmed]
  5. The urinary concentration of sialic acid is increased in non-insulin-dependent diabetic patients with microangiopathy: a possible useful marker for diabetic microangiopathy. Suzuki, K., Ishida, H., Sugimoto, C., Taguchi, Y., Matsuda, H., Nosaka, K., Someya, Y., Kadowaki, S., Seino, Y. Diabet. Med. (1995) [Pubmed]
  6. Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription. Yao, D., Taguchi, T., Matsumura, T., Pestell, R., Edelstein, D., Giardino, I., Suske, G., Ahmed, N., Thornalley, P.J., Sarthy, V.P., Hammes, H.P., Brownlee, M. Cell (2006) [Pubmed]
  7. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. Pennathur, S., Wagner, J.D., Leeuwenburgh, C., Litwak, K.N., Heinecke, J.W. J. Clin. Invest. (2001) [Pubmed]
  8. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. Calver, A., Collier, J., Vallance, P. J. Clin. Invest. (1992) [Pubmed]
  9. 15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease. Setty, B.N., Stuart, M.J. J. Clin. Invest. (1986) [Pubmed]
  10. Blockade of chlorpropamide-alcohol flushing by indomethacin suggests an association between prostaglandins and diabetic vascular complications. Barnett, A.H., Spiliopoulos, A.J., Pyke, D.A. Lancet (1980) [Pubmed]
  11. Increased platelet aggregation in early diabetus mellitus. Sagel, J., Colwell, J.A., Crook, L., Laimins, M. Ann. Intern. Med. (1975) [Pubmed]
  12. Immunohistochemical study of prostacyclin-stimulating factor (PSF) in the diabetic and atherosclerotic human coronary artery. Sekiguchi, N., Umeda, F., Masakado, M., Ono, Y., Hashimoto, T., Nawata, H. Diabetes (1997) [Pubmed]
  13. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Gisinger, C., Jeremy, J., Speiser, P., Mikhailidis, D., Dandona, P., Schernthaner, G. Diabetes (1988) [Pubmed]
  14. Pathogenesis of diabetic vascular disease: evidence for the role of reduced heparan sulfate proteoglycan. Jensen, T. Diabetes (1997) [Pubmed]
  15. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Corbett, J.A., Tilton, R.G., Chang, K., Hasan, K.S., Ido, Y., Wang, J.L., Sweetland, M.A., Lancaster, J.R., Williamson, J.R., McDaniel, M.L. Diabetes (1992) [Pubmed]
  16. Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Preston, F.E., Ward, J.D., Marcola, B.H., Porter, N.R., Timperley, W.R., O'Malley, B.C. Lancet (1978) [Pubmed]
  17. Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. Cagliero, E., Roth, T., Roy, S., Maiello, M., Lorenzi, M. J. Biol. Chem. (1991) [Pubmed]
  18. Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients. Koda, Y., Soejima, M., Yamagishi, S., Amano, S., Okamoto, T., Inagaki, Y., Yamada, K., Kimura, H. Diabetologia (2002) [Pubmed]
  19. Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. Platt, D.H., Bartoli, M., El-Remessy, A.B., Al-Shabrawey, M., Lemtalsi, T., Fulton, D., Caldwell, R.B. Free Radic. Biol. Med. (2005) [Pubmed]
  20. Troglitazone has a scavenging effect on reactive oxygen species. Inoue, I., Katayama, S., Takahashi, K., Negishi, K., Miyazaki, T., Sonoda, M., Komoda, T. Biochem. Biophys. Res. Commun. (1997) [Pubmed]
  21. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Cagliero, E., Roth, T., Roy, S., Lorenzi, M. Diabetes (1991) [Pubmed]
  22. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration. Williamson, J.R., Chang, K., Tilton, R.G., Prater, C., Jeffrey, J.R., Weigel, C., Sherman, W.R., Eades, D.M., Kilo, C. Diabetes (1987) [Pubmed]
  23. Role of galectin-3 in diabetic nephropathy. Iacobini, C., Amadio, L., Oddi, G., Ricci, C., Barsotti, P., Missori, S., Sorcini, M., Di Mario, U., Pricci, F., Pugliese, G. J. Am. Soc. Nephrol. (2003) [Pubmed]
  24. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy. Imano, E., Kanda, T., Nakatani, Y., Nishida, T., Arai, K., Motomura, M., Kajimoto, Y., Yamasaki, Y., Hori, M. Diabetes Care (1998) [Pubmed]
  25. Glucose and insulin modulate the capacity of endothelial cells (HUVEC) to express P-selectin and bind a monocytic cell line (U937). Puente Navazo, M.D., Chettab, K., Duhault, J., Koenig-Berard, E., McGregor, J.L. Thromb. Haemost. (2001) [Pubmed]
  26. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Bjarnegård, M., Enge, M., Norlin, J., Gustafsdottir, S., Fredriksson, S., Abramsson, A., Takemoto, M., Gustafsson, E., Fässler, R., Betsholtz, C. Development (2004) [Pubmed]
  27. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Yamagishi, S., Yonekura, H., Yamamoto, Y., Katsuno, K., Sato, F., Mita, I., Ooka, H., Satozawa, N., Kawakami, T., Nomura, M., Yamamoto, H. J. Biol. Chem. (1997) [Pubmed]
  28. Latent transforming growth factor-beta binding protein-1, a component of latent transforming growth factor-beta complex, accelerates the migration of aortic smooth muscle cells in diabetic rats through integrin-beta3. Kanzaki, T., Otabe, M. Diabetes (2003) [Pubmed]
  29. Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy. Chiarelli, F., Di Marzio, D., Santilli, F., Mohn, A., Blasetti, A., Cipollone, F., Mezzetti, A., Verrotti, A. Diabetes Care (2005) [Pubmed]
  30. Role of endothelin in diabetic vascular complications. Lam, H.C. Endocrine (2001) [Pubmed]
  31. Effects of acute insulin-induced hypoglycaemia on haemostasis, fibrinolysis and haemorheology in insulin-dependent diabetic patients and control subjects. Fisher, B.M., Quin, J.D., Rumley, A., Lennie, S.E., Small, M., MacCuish, A.C., Lowe, G.D. Clin. Sci. (1991) [Pubmed]
  32. Assays of serum laminin and type III procollagen peptide for monitoring the clinical course of diabetic microangiopathy. Okazaki, R., Matsuoka, K., Horiuchi, A., Maruyama, K., Okazaki, I. Diabetes Res. Clin. Pract. (1988) [Pubmed]
  33. Ticlopidine: a new platelet aggregation inhibitor. Ito, M.K., Smith, A.R., Lee, M.L. Clinical pharmacy. (1992) [Pubmed]
  34. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease. Solerte, S.B., Piovella, F., Viola, C., Schianca, G.C., Gamba, G., Fioravanti, M., Ferrari, E. Acta diabetologica latina. (1985) [Pubmed]
  35. Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients. Skrha, J., Prázný, M., Haas, T., Kvasnicka, J., Kalvodová, B. J. Diabetes Complicat. (2001) [Pubmed]
WikiGenes - Universities